Gaucher Disease News: Cerezyme Becomes First FDA-Approved Therapy for Type 3 Gaucher Disease New Treatment for Progressive Pulmonary Fibrosis Lung Disease The FDA approved Boehringer Ingelheims Jascayd (nerandomilast) tablets to treat adults with progressive pulmonary fibrosis (PPF)
For example, detergents and amphiphiles, such as ionic surfactants and anionic surfactants, as well as phospholipid vesicles and surfactants, might affect protein aggregation
Reconstitution is like opening that bag and leaving the book in the rain
A diagnosis code alone may not be sufficient
PlexusDx breaks down the safety considerations, contraindications, and how personalized assessment guides your treatment path
Medical Assistant (MA) or Licensed Practical Nurse (LPN) Handles vital signs, intake forms, lab prep, and patient flow